Skip to main content
Clinical Trials/NCT01205815
NCT01205815
Recruiting
Not Applicable

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Vanderbilt-Ingram Cancer Center1 site in 1 country3,000 target enrollmentJune 3, 2010
ConditionsMelanoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Melanoma
Sponsor
Vanderbilt-Ingram Cancer Center
Enrollment
3000
Locations
1
Primary Endpoint
Molecular changes in patients' melanoma tissue
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Registry
clinicaltrials.gov
Start Date
June 3, 2010
End Date
June 1, 2027
Last Updated
7 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Douglas Johnson

Associate Professor of Medicine

Vanderbilt-Ingram Cancer Center

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Molecular changes in patients' melanoma tissue

Time Frame: at 120 months

Tissue is collected upon consent or upon receipt of parafin block, primary aim will be met when all tissues are collected and analyzed at conclusion of study. Intent is to aid patients and their treating physician when making treatment decisions.

Secondary Outcomes

  • Improve the time between ordering the test and results entry into medical records(120 months)

Study Sites (1)

Loading locations...

Similar Trials